These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16598767)

  • 21. A study of monoclonal antibody-producing CHO cell lines: what makes a stable high producer?
    Chusainow J; Yang YS; Yeo JH; Toh PC; Asvadi P; Wong NS; Yap MG
    Biotechnol Bioeng; 2009 Mar; 102(4):1182-96. PubMed ID: 18979540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of chimeric antibody producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressure.
    Kim SJ; Kim NS; Ryu CJ; Hong HJ; Lee GM
    Biotechnol Bioeng; 1998 Apr; 58(1):73-84. PubMed ID: 10099263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of gene localization and accessibility in DHFR-amplified CHO cells.
    Jiang Z; Sharfstein ST
    Biotechnol Prog; 2009; 25(1):296-300. PubMed ID: 19224609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines.
    Yin JQ; Shen JN; Su WW; Wang J; Huang G; Jin S; Guo QC; Zou CY; Li HM; Li FB
    Acta Pharmacol Sin; 2007 May; 28(5):712-20. PubMed ID: 17439728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate-induced overexpression of functional glucocorticoid receptors in Chinese hamster ovary cells.
    Bellingham DL; Sar M; Cidlowski JA
    Mol Cell Endocrinol; 1992 Feb; 83(2-3):153-71. PubMed ID: 1547909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed.
    Hara T; Omura-Minamisawa M; Kang Y; Cheng C; Inoue T
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1485-95. PubMed ID: 18640498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significantly improvement of antibody expression level in CHO cells through downregulation of the DHFR gene in expression vector].
    Bai Y; Wang Y; Zhang HR; Zhou LJ; Lu YQ; Yu LZ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):62-4, 67. PubMed ID: 15132910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage.
    Kawamata H; Omotehara F; Nakashiro K; Uchida D; Shinagawa Y; Tachibana M; Imai Y; Fujimori T
    Int J Oncol; 2007 May; 30(5):1089-97. PubMed ID: 17390010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drosophila dihydrofolate reductase mutations confer antifolate resistance to mammalian cells.
    Affleck JG; Al-Batayneh KM; Neumann K; Cole SP; Walker VK
    Eur J Pharmacol; 2006 Jan; 529(1-3):71-8. PubMed ID: 16325803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of C-terminal deleted p53 isoforms in neuroblastoma.
    Goldschneider D; Horvilleur E; Plassa LF; Guillaud-Bataille M; Million K; Wittmer-Dupret E; Danglot G; de Thé H; Bénard J; May E; Douc-Rasy S
    Nucleic Acids Res; 2006; 34(19):5603-12. PubMed ID: 17028100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free radicals generated by ionizing radiation signal nuclear translocation of p53.
    Martinez JD; Pennington ME; Craven MT; Warters RL; Cress AE
    Cell Growth Differ; 1997 Sep; 8(9):941-9. PubMed ID: 9300177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer amplified sequence 2, a novel negative regulator of the p53 tumor suppressor.
    Kuo PC; Tsao YP; Chang HW; Chen PH; Huang CW; Lin ST; Weng YT; Tsai TC; Shieh SY; Chen SL
    Cancer Res; 2009 Dec; 69(23):8877-85. PubMed ID: 19903847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SV40 oncoproteins enhance asbestos-induced DNA double-strand breaks and abrogate senescence in murine mesothelial cells.
    Pietruska JR; Kane AB
    Cancer Res; 2007 Apr; 67(8):3637-45. PubMed ID: 17440075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.
    Mannefeld M; Klassen E; Gaubatz S
    Cancer Res; 2009 May; 69(9):4073-80. PubMed ID: 19383908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status.
    Martelli L; Di Mario F; Botti P; Ragazzi E; Martelli M; Kelland L
    Biochem Pharmacol; 2007 Jun; 74(1):20-7. PubMed ID: 17466278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of heterogeneous nuclear ribonucleoprotein C1/C2 with a novel cis-regulatory element within p53 mRNA as a response to cytostatic drug treatment.
    Christian KJ; Lang MA; Raffalli-Mathieu F
    Mol Pharmacol; 2008 May; 73(5):1558-67. PubMed ID: 18296503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional characterization of a new p53 mutant generated by homozygous deletion in a neuroblastoma cell line.
    Nakamura Y; Ozaki T; Niizuma H; Ohira M; Kamijo T; Nakagawara A
    Biochem Biophys Res Commun; 2007 Mar; 354(4):892-8. PubMed ID: 17276397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear translocation of dihydrofolate reductase is not a pre-requisite for DNA damage induced apoptosis.
    Yuan TT; Huang Y; Zhou CX; Yu Y; Wang LS; Zhuang HY; Chen GQ
    Apoptosis; 2009 May; 14(5):699-710. PubMed ID: 19360472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytoplasmic mutant p53 increases Bcl-2 expression in estrogen receptor-positive breast cancer cells.
    Pratt MA; White D; Kushwaha N; Tibbo E; Niu MY
    Apoptosis; 2007 Apr; 12(4):657-69. PubMed ID: 17252199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of class II beta-tubulin expression by tumor suppressor p53 protein in mouse melanoma cells in response to Vinca alkaloid.
    Arai K; Matsumoto Y; Nagashima Y; Yagasaki K
    Mol Cancer Res; 2006 Apr; 4(4):247-55. PubMed ID: 16603638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.